固定剂量组合疗法对心血管死亡率和事件的全球影响,2023-2050年:一个建模研究
David A Watkins1, Sarah J Pickersgill2, David Flood3
1Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Global Health, University of Washington, Seattle, Washington, USA.
Journal of the American College of Cardiology
|July 16, 2025
概括
单片组合疗法 (SPC) 的广泛采用可以防止全球数以百万计的心血管死亡和事件. 实施SPC,特别是在摄入量较低的地区,可以显著降低过早死亡率并加速实现健康目标.
科学领域:
- 预防心血管疾病预防心血管疾病
- 公共卫生干预措施 公共卫生干预
- 药物经济学 药物经济学
背景情况:
- 全球心血管疾病 (CVD) 预防药物吸收率低.
- 单片药剂组合疗法 (SPC) 是一个有希望的但未得到充分利用的解决方案.
- SPC疗法结合了他类药物和抗高血压药物,有或没有阿司匹林.
研究的目的:
- 模拟从2023年到2050年广泛采用SPC疗法的潜在影响.
- 为了比较针对性和基于人口的SPC推广策略.
- 预计减少心脏病相关死亡和非致命事件.
主要方法:
- 在182个国家进行国家过渡和人口模型.
- 模拟两个SPC推广场景:目标和基于人口的.
- 对采用,坚持和阿司匹林效应的敏感性分析.
主要成果:
- 到2050年,有可能预防高达7200万例死亡和1.3亿例病例.
- 由于人口规模,预计南亚和东亚/太平洋地区的影响最大.
- 减少所有原因过早死亡率2.0%3.2%.
结论:
- SPC疗法可以显著加快降低心血管疾病死亡率的进展.
- 增加预防性药物的使用,特别是在低吸收环境中,是关键.
- 广泛采用SPC支持CVD的全球健康目标.
相关概念视频
Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
178
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
178
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Heart Failure V: Medical Management
27
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
27
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K


